Insider · CIK 0001602396
Nicole R. Hadas
Files at: AKBA. On EDGAR ↗
Reported trades — common stock
| Trade | Reported (ET) | Company | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 28, 2019 AForm 4 → | Mar 5, 4:06 pm EST | Akebia Therapeutics, Inc.AKBA | 65,000 | — | — | 166,735 | — | plan? late |
| Dec 12, 2018 FForm 4 → | Dec 13, 8:15 am EST | Akebia Therapeutics, Inc.AKBA | 20,175 | $8.94 | $180,365 | 101,284 | — | plan? |
| Feb 28, 2018 AForm 4 → | Mar 2, 4:15 pm EST | Akebia Therapeutics, Inc.AKBA | 17,500 | — | — | 120,078 | — | plan? |
| Oct 2, 2017 SForm 4 → | Oct 4, 4:21 pm EDT | Akebia Therapeutics, Inc.AKBA | 7,803 | $19.89 | $155,188 | 101,804 | −7.12% | plan? |
| Jul 3, 2017 SForm 4 → | Jul 6, 12:24 pm EDT | Akebia Therapeutics, Inc.AKBA | 1,554 | $14.26 | $22,156 | 109,607 | −1.40% | plan? |
| Apr 3, 2017 SForm 4 → | Apr 4, 4:01 pm EDT | Akebia Therapeutics, Inc.AKBA | 1,556 | $9.18 | $14,280 | 109,856 | −1.40% | plan? |
| Feb 21, 2017 AForm 4 → | Feb 23, 4:02 pm EST | Akebia Therapeutics, Inc.AKBA | 28,500 | — | — | 111,412 | — | plan? |
| Jan 1, 2017 SForm 4 → | Jan 3, 4:01 pm EST | Akebia Therapeutics, Inc.AKBA | 1,810 | $10.49 | $18,988 | 82,912 | −2.14% | plan? |
| Oct 1, 2016 SForm 4 → | Oct 4, 4:12 pm EDT | Akebia Therapeutics, Inc.AKBA | 1,556 | $8.95 | $13,934 | 83,915 | −1.82% | plan? |
| Jul 5, 2016 SForm 4 → | Jul 6, 4:08 pm EDT | Akebia Therapeutics, Inc.AKBA | 1,557 | $7.47 | $11,625 | 85,471 | −1.79% | plan? |
| Apr 4, 2016 SForm 4 → | Apr 5, 4:03 pm EDT | Akebia Therapeutics, Inc.AKBA | 1,556 | $9.41 | $14,642 | 85,528 | −1.79% | plan? |
| Feb 22, 2016 AForm 4 → | Feb 24, 4:06 pm EST | Akebia Therapeutics, Inc.AKBA | 22,500 | — | — | 87,084 | — | plan? |
| Jan 4, 2016 SForm 4 → | Jan 6, 4:04 pm EST | Akebia Therapeutics, Inc.AKBA | 1,811 | $12.28 | $22,239 | 64,584 | −2.73% | plan? |
| Oct 2, 2015 SForm 4 → | Oct 5, 4:02 pm EDT | Akebia Therapeutics, Inc.AKBA | 1,484 | $8.67 | $12,860 | 65,260 | −2.22% | plan? |
| Jul 2, 2015 SForm 4 → | Jul 6, 4:03 pm EDT | Akebia Therapeutics, Inc.AKBA | 1,484 | $9.54 | $14,160 | 66,744 | −2.18% | plan? |
| Apr 2, 2015 SForm 4/A → | Jul 2, 7:29 am EDT | Akebia Therapeutics, Inc.AKBA | 1,483 | $9.09 | $13,478 | 67,015 | −2.17% | plan? |
| Apr 2, 2015 SForm 4 → | Apr 6, 4:13 pm EDT | Akebia Therapeutics, Inc.AKBA | 1,483 | $9.09 | $13,478 | 76,093 | −1.91% | plan? amended |
| Apr 1, 2015 AForm 4 → | Apr 6, 4:13 pm EDT | Akebia Therapeutics, Inc.AKBA | 4,539 | $9.51 | $43,166 | 77,576 | — | plan? amended |
| Jan 2, 2015 SForm 4/A → | Jul 2, 7:27 am EDT | Akebia Therapeutics, Inc.AKBA | 1,715 | $11.46 | $19,655 | 68,498 | −2.44% | plan? |
| Jan 2, 2015 SForm 4 → | Jan 5, 4:35 pm EST | Akebia Therapeutics, Inc.AKBA | 1,715 | $11.46 | $19,655 | 73,037 | −2.29% | plan? amended |
| Jan 1, 2015 AForm 4 → | Jan 5, 4:35 pm EST | Akebia Therapeutics, Inc.AKBA | 4,539 | $11.64 | $52,834 | 74,752 | — | plan? amended |
Reported trades — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Company | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 28, 2019 AForm 4 → | Mar 5, 4:06 pm EST | Akebia Therapeutics, Inc.AKBA | 100,000 | — | — | 100,000 | — | late |
| Feb 28, 2018 AForm 4 → | Mar 2, 4:15 pm EST | Akebia Therapeutics, Inc.AKBA | 25,000 | — | — | 25,000 | — | |
| Feb 21, 2017 AForm 4 → | Feb 23, 4:02 pm EST | Akebia Therapeutics, Inc.AKBA | 45,000 | $10.14 | $456,300 | 45,000 | — | |
| Feb 22, 2016 AForm 4 → | Feb 24, 4:06 pm EST | Akebia Therapeutics, Inc.AKBA | 34,300 | — | — | 34,300 | — | |
| Mar 6, 2015 AForm 4 → | Mar 10, 4:10 pm EDT | Akebia Therapeutics, Inc.AKBA | 30,000 | — | — | 30,000 | — |